PolyCore Therapeutics Awarded $1.5 Million NIH Grant to Advance Lead Compound, PCT-3012
August 20, 2020
PHILADELPHIA, Pa, August 20, 2020 — PolyCore Therapeutics LLC, a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative… Read More
